Cellvera & Lifenity International Announce Global Partnership Offering a “Test to Treat” for COVID-19 Patients
Game-changing “test to treat” program rolled out across India, allowing patients to receive COVID-19 antiviral Qifenda 400MG after a positive diagnosis UNITED STATES, April 26, 2022 /EINPresswire.com/ — Cellvera, a US commercial-stage biopharmaceutical company focused on discovering and developing antiviral therapies across a broad spectrum of infectious diseases. Lifenity International (“Lifenity”), India’s largest healthcare PSU, […]